Fosun brings UK particle therapy to mainland China in advanced cancer care push
AdvertisementChina’s private sectorBusinessChina BusinessFosun brings UK particle therapy to mainland China in push for advanced cancer careThe US Food and Drug Administration-approved Marie system promises human-centred care, advanced technology and lower costs
Reading Time:2 minutesWhy you can trust SCMPDaniel Renin ShanghaiPublished: 7:30am, 7 Nov 2025Fosun Pharmaceutical, a leading healthcare group, has taken a substantial step towards introducing particle therapy systems to hospitals in mainland China, aligning with Beijing’s efforts to make advanced medical treatment accessible to cancer patients across the country.AdvertisementThe Shanghai-based company, a subsidiary of China’s non-state-owned conglomerate Fosun International, formed a partnership with Leo Cancer Care on Thursday, pledging to distribute the UK firm’s Marie medical facilities in the world’s largest consumer market. The deal came three months after the UK company secured regulatory clearance for the Marie system f..
